Shigeko Hara
- Nephrology top 0.2%
- Endocrinology, Diabetes and Metabolism top 1%
- Surgery top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Yoshifumi UbaraHirohito SoneSatoru KodamaHiroshi TsujiYoriko HeianzaYasuji AraseHirofumi MakinoNaoki Sawa
- Topics
- Dialysis and Renal Disease Management (21 papers)Renal Diseases and Glomerulopathies (21 papers)Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers)
- Partner nations
- JapanUnited StatesNew Zealand
In The Last Decade
Shigeko Hara
118 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 114
- Nephrology 1.9k
- Endocrinology, Diabetes and Metabolism 849
- Surgery 746
- Molecular Biology 609
- Pulmonary and Respiratory Medicine 569
Countries citing papers authored by Shigeko Hara
This map shows the geographic impact of Shigeko Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeko Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeko Hara more than expected).
Fields of papers citing papers by Shigeko Hara
This network shows the impact of papers produced by Shigeko Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeko Hara. The network helps show where Shigeko Hara may publish in the future.
Co-authorship network of co-authors of Shigeko Hara
This figure shows the co-authorship network connecting the top 25 collaborators of Shigeko Hara. A scholar is included among the top collaborators of Shigeko Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeko Hara. Shigeko Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 27 | |
| 3 | 85 | |
| 4 | 34 | |
| 5 | 7 | |
| 6 | 46 | |
| 7 | 5 | |
| 8 | 27 | |
| 9 | 15 | |
| 10 | 34 | |
| 11 | 6 | |
| 12 | 3 | |
| 13 | 1 | |
| 14 | 7 | |
| 15 | Vancomycin pharmacokinetics and dosing recommendations in patients undergoing hemodialysis | 1 |
| 16 | 63 | |
| 17 | 28 | |
| 18 | 28 | |
| 19 | 28 | |
| 20 | 7 |
About Shigeko Hara
Shigeko Hara is a scholar working on Nephrology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 123 papers that have together received 3.8k indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (21 papers), Renal Diseases and Glomerulopathies (21 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (17 papers). The work is most often cited by research in Nephrology (1.9k citations), Endocrinology, Diabetes and Metabolism (849 citations) and Pathology and Forensic Medicine (487 citations). Shigeko Hara has collaborated with scholars based in Japan, United States and New Zealand. Frequent co-authors include Yoshifumi Ubara, Hirohito Sone, Satoru Kodama, Hiroshi Tsuji, Yoriko Heianza, Yasuji Arase, Hirofumi Makino, Naoki Sawa, Fumi Takemoto and Kunitoshi Iseki. Their work appears in journals such as The Lancet, PLoS ONE and American Journal of Clinical Nutrition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.